SCHEMBL21067433

SCHEMBL21067433

CC(C)CC(N)C(=O)NC1CCCN(S(=O)(=O)c2ccccn2)CC1=O

nearest known ligand 0.68

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CTSK P43235 18/20 0.68
CTSL P07711 16/20 0.68
CTSS P25774 12/20 0.68
CTSB P07858 6/20 0.67
CTSV O60911 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4171722 1.00 CTSK (0.68) CTSKCTSLCTSSCTSBCTSV
SCHEMBL5092521 0.91 CTSK (0.60) CTSKCTSLCTSSCTSBCTSV
SCHEMBL5098780 0.90 CTSK (0.60) CTSKCTSLCTSSCTSBCTSV
SCHEMBL5105547 0.90 CTSK (0.63) CTSKCTSLCTSSCTSBCTSV
SCHEMBL5093274 0.89 CTSK (0.59) CTSKCTSLCTSSCTSBCTSV
SCHEMBL6227436 0.89 CTSK (0.62) CTSKCTSLCTSSCTSBCTSV
SCHEMBL6629716 0.89 CTSK (0.62) CTSKCTSLCTSSCTSBCTSV
SCHEMBL6805745 0.89 CTSK (0.62) CTSKCTSLCTSSCTSBCTSV
SCHEMBL4833031 0.88 CTSK (0.69) CTSKCTSLCTSSCTSBCTSV
SCHEMBL7596034 0.88 CTSK (0.58) CTSKCTSLCTSSCTSBCTSV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed